Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial

Protocol No
AFT-25-COMET
Principal Investigator
Tina Yen
Phase
III
Summary
The purpose of this study is to compare the risks and benefits of the usual treatment approach for DCIS compared to the close monitoring approach. There will be about 1200 women taking part in the study.
Description
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Share This: